
Cyclomed Technologies
A Spanish deeptech company expert in superconductivity and cryogenics applied to the health sector.
EUR | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | - | - | 446 % | - | 40 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | - | (348 %) | (17 %) | - | - |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | - | (351 %) | (19 %) | - | - |
EV | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article, Dealroom estimates
Related Content
Cyclomed Technologies, founded in 2019, is a spin-off from the Center for Energy, Environmental and Technological Research (CIEMAT). The company specializes in developing and commercializing superconducting and cryogenic technologies. Cyclomed operates in the deeptech sector, focusing on creating innovative technological solutions and products for various industries, including healthcare and energy.
Cyclomed's primary product is a compact cyclotron accelerator, which is used to produce short-lived radioisotopes. These radioisotopes are crucial in medical imaging and cancer treatment, making Cyclomed a key player in the healthcare technology market. The company also develops energy storage systems, contributing to the energy transition by providing advanced solutions for storing and managing energy efficiently.
Cyclomed collaborates with leading research centers and companies worldwide to bring its products from concept to market. This collaborative approach ensures that their products are at the forefront of technological advancements. The company's business model revolves around research and development, followed by the commercialization of its innovative products. Cyclomed generates revenue through the sale of these advanced technological solutions and products.
The team at Cyclomed is composed of experts with extensive backgrounds in superconducting and cryogenic technologies, which inspires confidence in their clients. Their passion for excellence and commitment to continuous improvement drive the company's success.
In summary, Cyclomed Technologies is a deeptech company that develops and commercializes advanced superconducting and cryogenic technologies for healthcare and energy sectors. They collaborate with top research centers and companies to bring innovative products to market, generating revenue through product sales.
Keywords: Cyclotron, Radioisotopes, Superconducting, Cryogenic, Healthcare, Energy Storage, Deeptech, Innovation, Research Collaboration, Commercialization.